SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock Up Expiration Hell Portfolio: Wave II
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Madharry who wrote (27)6/25/2004 3:27:02 AM
From: tuck  Read Replies (2) of 107
 
SNMX, the taste receptor company, I remember now. The discovery process is as long as for drugs, but the regulatory process is much shorter. Still, they only have two candidates headed for the regulatory hurdles soon, and their partner is only likely to select one.

S-1:

sec.gov

Vertex (via Aurora) and Incyte apparently have a stake, as they were holding some convertible preferred. Senior management hasn't been with the company for long because it's only five years old. IP early -- pending applications, none granted -- and thus murky. Almost alone in their niche except for a private outfit called Linguagen, though it's possible the big flavorings companies have similar programs (I doubt it). But I agree, I'm not going to run out and buy this one right away.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News